← daily scanner dashboard

#10 AMN — AMN HEALTHCARE SERVICES INC

A2_VCP_NEAR_PIVOT | as of 2026-09-25 | automated relative priority, not a published Minervini point formula

Relative priority42.50
RS rating89.27
Fundamental strength8.33
VCP score90.48
Pivot distance0.20%
AV confirmation80.00%complete
Technical chart for AMN

Trend Template

price_above_sma150_and_sma200PASS
sma150_above_sma200PASS
sma200_rising_1mPASS
sma50_above_sma150_and_sma200PASS
price_above_sma50PASS
price_at_least_30pct_above_52w_lowPASS
price_within_25pct_of_52w_highPASS
rs_rating_at_least_70PASS

Trend Template metrics

close34.56
sma5034.08
sma15027.99
sma20025.43
sma200_1m_ago23.51
pct_above_52w_low130.86
pct_below_52w_high7.15
rs_rating89.27

VCP conditions

coherent_contraction_sequencePASS
enough_contractionsPASS
successive_ranges_inside_firstPASS
successive_depths_contractingPASS
final_contraction_tightPASS
base_depth_okPASS
resistance_area_tightPASS
volume_dryupFAIL
atr_contractingPASS
price_tightPASS
near_pivotPASS

VCP metrics

num_contractions2.00
contraction_depths_pct[9.67, 5.69]
depth_ratios_vs_prior[0.588]
target_depth_ratio_roughly_half0.50
max_allowed_depth_ratio0.80
base_high35.46
base_low32.03
base_depth_pct9.67
base_duration_weeks4.00
resistance_spread_pct2.34
volume_dryup_ratio_10d_vs_50d0.96
atr_pct_recent3.63
atr_pct_prior5.14
atr_contraction_ratio0.71
tight_10d_range_pct6.44
raw_contraction_count11.00
raw_depths_pct[8.52, 7.53, 19.3, 9.96, 9.51, 14.94, 9.24, 14.89, 11.34, 9.67, 5.69]
final_trough_age_bars11.00
selection_reasoncoherent_current_sequence
pivot_price34.63
distance_to_pivot_pct0.20
vcp_score_pct90.48
is_vcp_candidatePASS
breakout_on_volumeFAIL

Price / volume

return_1m_pct0.93
return_3m_pct5.49
return_6m_pct76.51
return_12m_pct88.44
weighted_12m_momentum17.59
range_10d_pct6.44
range_20d_pct11.02
avg_volume_50d653,008
dollar_volume_50d22.57M
up_down_volume_ratio_50d0.86
accumulation_days_20d2.00
distribution_days_20d3.00

Fundamental overlay criteria

eps_growth_minimumPASS
sales_growth_positive_or_betterPASS
core_data_coveragePASS
eps_acceleratingFAIL
sales_acceleratingFAIL
gross_margin_improvingPASS
operating_margin_improvingPASS

Minervini-oriented SEC fundamentals

eps_growth_yoy_pct117.55
eps_previous_q_yoy_growth_pct5,400
eps_acceleration_pts-5,282
eps_annual_growth_pct35.58
eps_cagr_3y_pct—
sales_growth_yoy_pct2.29
sales_previous_q_yoy_growth_pct99.90
sales_acceleration_pts-97.61
sales_annual_growth_pct-8.49
sales_cagr_3y_pct-19.55
gross_margin_pct30.58
operating_margin_pct4.00
pretax_margin_pct2.96
net_margin_pct3.14
gross_margin_yoy_change_pts0.74
operating_margin_yoy_change_pts22.79
roe_latest_fy_pct-14.19
current_ratio1.13
debt_to_equity_pct—
cash_to_debt—
shares_outstanding—
adjusted_eps_growth_yoy_pct—
earnings_surprise_pct—
eps_estimate_revision_30d_pct—
analyst_count—
institutional_ownership_pct—
institutional_qoq_change_pct—
management_guidance_revision_pct—

SEC data quality

core_coverage_pct90.00
missing_core_metrics["shares_outstanding"]
selected_sec_tags{"accounts_payable": "us-gaap:AccountsPayableCurrent", "accounts_receivable": "us-gaap:AccountsReceivableNetCurrent", "capex": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "cash": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "cost_of_revenue": "us-gaap:CostOfRevenue", "current_assets": "us-gaap:AssetsCurrent", "current_liabilities": "us-gaap:LiabilitiesCurrent", "dividends_paid": null, "eps_basic": "us-gaap:EarningsPerShareBasic", "eps_diluted": "us-gaap:EarningsPerShareDiluted", "equity": "us-gaap:StockholdersEquity", "gross_profit": "us-gaap:GrossProfit", "inventory": null, "long_term_debt": "us-gaap:LongTermDebtNoncurrent", "long_term_debt_current": "us-gaap:LongTermDebtCurrent", "net_income": "us-gaap:NetIncomeLoss", "operating_cash_flow": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "operating_income": "us-gaap:OperatingIncomeLoss", "pretax_income": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "r_and_d": null, "revenue": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "sga": "us-gaap:SellingGeneralAndAdministrativeExpense", "share_repurchases": "us-gaap:PaymentsForRepurchaseOfCommonStock", "shares_outstanding": "dei:EntityCommonStockSharesOutstanding", "short_term_debt": null, "short_term_investments": null, "stock_based_comp": "us-gaap:ShareBasedCompensation", "total_assets": "us-gaap:Assets", "total_liabilities": "us-gaap:Liabilities", "weighted_avg_diluted_shares": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"}
unavailable_canonical_concepts["dividends_paid", "inventory", "r_and_d", "short_term_debt", "short_term_investments"]
warnings["Standalone Q4 income/EPS can be absent because 10-K statements are annual.", "Company-specific extension tags are not returned by CompanyFacts.", "Non-GAAP EPS, guidance, 13F ownership, Form 4 activity, and analyst estimates are separate modules."]

Reporting periods

latest_quarter_end2026-06-30
latest_quarter_filed2026-08-07
latest_fiscal_year_end2025-12-31
latest_balance_sheet_end2026-06-30

Company metadata

symbolAMN
cik1.14M
company_nameAMN HEALTHCARE SERVICES INC
exchange—
sic7,363
sic_descriptionServices-Help Supply Services
fiscal_year_end1,231
as_of2026-09-25
sourceSEC EDGAR CompanyFacts + Submissions

Alpha Vantage enrichment

latest_reported_date2026-08-06
latest_reported_eps0.77
latest_estimated_eps0.22
latest_earnings_surprise_pct250.00
avg_earnings_surprise_4q_pct89.03
positive_earnings_surprises_4q3.00
earnings_surprise_quarters_available4.00
reported_eps_yoy_growth_pct156.67
estimate_period2027-12-31
analyst_count_eps—
analyst_count_revenue—
eps_estimate_avg—
revenue_estimate_avg—
estimate_revision.eps_estimate_revision_up_trailing_7_days1.00
estimate_revision.eps_estimate_revision_up_trailing_30_days3.00
estimate_revision.eps_estimate_revision_down_trailing_30_days6.00
eps_revision_up_30d3.00
eps_revision_down_30d6.00
eps_revision_net_up_30d-3.00
institutional.total_institutional_holders338.00
institutional.total_institutional_shares50.82M
institutional.holders_with_increased_holdings187.00
institutional.holders_with_decreased_holdings122.00
institutional.holders_with_unchanged_holdings29.00
institutional_holder_rows338.00
institutional_total_shares50.82M
endpoints_returned["EARNINGS", "EARNINGS_ESTIMATES", "INSTITUTIONAL_HOLDINGS"]

Alpha Vantage confirmation screen

latest_earnings_surprise_positivePASS
average_4q_earnings_surprise_positivePASS
positive_surprise_quartersPASS
analyst_coverage_present—
eps_revision_breadth_nonnegative_30dFAIL
institutional_sponsorship_presentPASS

Alpha Vantage screen summary

statuscomplete
confirmation_score_pct80.00
available_criteria5.00
noteInformational post-Exp0 confirmation only; not part of validated Exp0 selection/ranking.

Alpha Vantage endpoint status

EARNINGScache_available
EARNINGS_ESTIMATEScache_available
INSTITUTIONAL_HOLDINGScache_available

Accepted VCP contractions

peak_datepeak_pricetrough_datetrough_pricedepth_pctdepth_ratio_vs_priorbars
2026-08-2835.462026-09-0332.039.67—4.00
2026-09-1034.632026-09-1032.665.690.590.00

Recent SEC filings

formfiling_dateaccession_numberprimary_document
10-Q2026-08-070001628280-26-054507amn-20260630.htm
8-K2026-08-060001142750-26-000008amn-20260806.htm
10-Q2026-05-080001628280-26-032419amn-20260331.htm
8-K2026-05-070001142750-26-000007amn-20260507.htm
8-K2026-05-040001104659-26-054478tm2613325d1_8k.htm
10-K2026-02-200001628280-26-009918amn-20251231.htm
8-K2026-02-190001142750-26-000003amn-20260219.htm
8-K2026-02-050000950142-26-000299eh260734884_8k.htm
8-K2026-01-140001142750-26-000001amn-20260114.htm
8-K2025-12-110001142750-25-000058amn-20251211.htm
10-Q2025-11-070001628280-25-050362amn-20250930.htm
8-K2025-11-060001142750-25-000056amn-20251106.htm

SEPA factors not covered by SEC + Yahoo

These remain manual or require another provider/module and are deliberately not guessed: